A twist in the tale at struggling cinema chain AMC
American cinema chain AMC may have secured a new lease of life now that it has become the new GameStop. Matthew Partridge reports.
Normally, the first week of June would see the summer blockbuster season in full swing, says Lex in the Financial Times. This year however, “the blockbuster is the cinema”. AMC Entertainment Holdings has become the latest “meme stock” – a stock that suddenly becomes fashionable among individual investors, with word of mouth and social-media hype, rather than fundamentals, underpinning interest. GameStop is the classic recent example.
AMC’s shares have surged by around 465% in the past month. Distressed debt trader Jason Mudrick bought $230m of stock from the company last week “only to flip it within hours and lock in a profit of perhaps $30m”. Shortly afterwards AMC shares doubled again, “aided by the offer of free popcorn for retail investors”. The group then decided to cash in on the surge by selling more stock.
Those investors who got ahead of the latest surge may have done well, but AMC’s long-term future seems far from rosy, says Tara Lachapelle on Bloomberg. The company has “more than $5bn in debt and $5bn in operating lease liabilities”. Nor does the end of lockdown “mean new riches for this industry”, at least not in the US. Attendance has been in a “slow and steady decline” for years. And Disney, whose blockbusters are AMC’s “main draws”, is devoting “financial and creative resources” to its own streaming service, Disney+.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
An extremely risky investment
Even AMC itself doesn’t believe that its current valuations reflect reality, says Joe Wallace in The Wall Street Journal. At the same time as announcing plans to sell more shares, it warned potential buyers that “that they might lose all their money”, and admitted in a regulatory filing that market prices “reflect market and trading dynamics unrelated to our underlying business”.
It’s true that purchasers could end up making “substantial losses”, says Alistair Osborne in The Times. Still, at least AMC has been “smart enough” to take advantage of the boom, raising $1.25bn from selling more shares at prices it could previously “only have dreamt” of. Given that such equity sales strengthen the company, perhaps other companies, including Cineworld, AMC’s “debt-addicted UK rival” should consider “handing out the popcorn” and trying to tap into the “meme stock” vibe, or at least paying attention to retail investors.
Interest from retail investors may help assuage doubts about AMC’s survival, but it may ultimately prove to be a double-edged sword, says Sarah Whitten on CNBC: AMC will need to keep investors propping up the company long enough for its “business to stabilise”. Already, its CEO has indicated that instead of using the cash raised to “get its finances back on track or focus on paying down its massive debt”, it will use at least some of the money for “potential acquisitions”, thus “doubling down” on the strategy that got it into trouble in the first place.
Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.
He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.
Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.
As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.
Follow Matthew on Twitter: @DrMatthewPartri
-
Rightmove: Asking prices edge closer to record peak
Asking prices have been driven up by the top-end of the market, Rightmove has found. But how does the situation look in your area?
By Vaishali Varu Published
-
Coventry Building Society bids £780m for Co-operative Bank - what could it mean for customers?
Coventry Building Society has put in an offer of £780 million to buy Co-operative Bank. When will the potential deal happen and what could it mean for customers?
By Vaishali Varu Published
-
The industry at the heart of global technology
The semiconductor industry powers key trends such as artificial intelligence, says Rupert Hargreaves
By Rupert Hargreaves Published
-
Three emerging Asian markets to invest in
Professional investor Chetan Sehgal of Templeton Emerging Markets Investment Trust tells us where he’d put his money
By Chetan Sehgal Published
-
What to consider before investing in small-cap indexes
Small-cap index trackers show why your choice of benchmark can make a large difference to long-term returns
By Cris Sholto Heaton Published
-
Why space investments are the way to go for investors
Space investments will change our world beyond recognition, UK investors should take note
By Merryn Somerset Webb Published
-
Time to tap into Africa’s mobile money boom
Favourable demographics have put Africa on the path to growth when it comes to mobile money and digital banking
By Rupert Hargreaves Published
-
M&S is back in fashion: but how long can this success last?
M&S has exceeded expectations in the past few years, but can it keep up the momentum?
By Rupert Hargreaves Published
-
The end of China’s boom
Like the US, China too got fat on fake money. Now, China's doom is not far away.
By Bill Bonner Published
-
Magic mushrooms — an investment boom or doom?
Investing in these promising medical developments might see you embark on the trip of a lifetime.
By Bruce Packard Published